The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code - PubMed (original) (raw)
. 2005 Jul 1;280(26):24824-38.
doi: 10.1074/jbc.M502115200. Epub 2005 May 3.
Affiliations
- PMID: 15870070
- DOI: 10.1074/jbc.M502115200
Free article
The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code
Jason E Fish et al. J Biol Chem. 2005.
Free article
Abstract
Expression of endothelial nitric-oxide synthase (eNOS) mRNA is highly restricted to the endothelial cell layer of medium to large sized arterial blood vessels. Here we assessed the chromatin environment of the eNOS gene in expressing and nonexpressing cell types. Within endothelial cells, but not a variety of nonendothelial cells, the nucleosomes that encompassed the eNOS core promoter and proximal downstream coding regions were highly enriched in acetylated histones H3 and H4 and methylated lysine 4 of histone H3. This differentially modified chromatin domain was selectively associated with functionally competent RNA polymerase II complexes. Endothelial cells were particularly enriched in acetylated histone H3 lysine 9, histone H4 lysine 12, and di- and tri-methylated lysine 4 of histone H3 at the core promoter. Histone modifications at this region, which we have previously demonstrated to exhibit cell-specific DNA methylation, were functionally relevant to eNOS expression. Inhibition of histone deacetylase activity by trichostatin A increased acetylation of histones H3 and H4 at the eNOS proximal promoter in nonexpressing cell types and led to increased steady-state eNOS mRNA transcript levels. H3 lysine 4 methylation was also essential for eNOS expression, since treatment of endothelial cells with methylthioadenosine, a known lysine 4 methylation inhibitor, decreased eNOS RNA levels, H3 lysine 4 methylation, and RNA polymerase II loading at the eNOS proximal promoter. Importantly, methylthioadenosine also prevented the trichostatin A-mediated increase in eNOS mRNA transcript levels in nonendothelial cells. Taken together, these findings provide strong evidence that the endothelial cell-specific expression of eNOS is controlled by cell-specific histone modifications.
Similar articles
- The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation.
Chan Y, Fish JE, D'Abreo C, Lin S, Robb GB, Teichert AM, Karantzoulis-Fegaras F, Keightley A, Steer BM, Marsden PA. Chan Y, et al. J Biol Chem. 2004 Aug 13;279(33):35087-100. doi: 10.1074/jbc.M405063200. Epub 2004 Jun 4. J Biol Chem. 2004. PMID: 15180995 - Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase.
Gan Y, Shen YH, Wang J, Wang X, Utama B, Wang J, Wang XL. Gan Y, et al. J Biol Chem. 2005 Apr 22;280(16):16467-75. doi: 10.1074/jbc.M412960200. Epub 2005 Feb 19. J Biol Chem. 2005. PMID: 15722551 Free PMC article. - Induction of KLF2 by fluid shear stress requires a novel promoter element activated by a phosphatidylinositol 3-kinase-dependent chromatin-remodeling pathway.
Huddleson JP, Ahmad N, Srinivasan S, Lingrel JB. Huddleson JP, et al. J Biol Chem. 2005 Jun 17;280(24):23371-9. doi: 10.1074/jbc.M413839200. Epub 2005 Apr 15. J Biol Chem. 2005. PMID: 15834135 - Endothelial nitric oxide synthase: insight into cell-specific gene regulation in the vascular endothelium.
Fish JE, Marsden PA. Fish JE, et al. Cell Mol Life Sci. 2006 Jan;63(2):144-62. doi: 10.1007/s00018-005-5421-8. Cell Mol Life Sci. 2006. PMID: 16416260 Free PMC article. Review. - Histone modifications and nuclear architecture: a review.
Bártová E, Krejcí J, Harnicarová A, Galiová G, Kozubek S. Bártová E, et al. J Histochem Cytochem. 2008 Aug;56(8):711-21. doi: 10.1369/jhc.2008.951251. Epub 2008 May 12. J Histochem Cytochem. 2008. PMID: 18474937 Free PMC article. Review.
Cited by
- The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.
Petruzziello-Pellegrini TN, Yuen DA, Page AV, Patel S, Soltyk AM, Matouk CC, Wong DK, Turgeon PJ, Fish JE, Ho JJ, Steer BM, Khajoee V, Tigdi J, Lee WL, Motto DG, Advani A, Gilbert RE, Karumanchi SA, Robinson LA, Tarr PI, Liles WC, Brunton JL, Marsden PA. Petruzziello-Pellegrini TN, et al. J Clin Invest. 2012 Feb;122(2):759-76. doi: 10.1172/JCI57313. Epub 2012 Jan 9. J Clin Invest. 2012. PMID: 22232208 Free PMC article. - The Safety of Pharmacological and Surgical Treatment of Diabetes in Patients with Diabetic Retinopathy-A Review.
Matuszewski W, Baranowska-Jurkun A, Stefanowicz-Rutkowska MM, Gontarz-Nowak K, Gątarska E, Bandurska-Stankiewicz E. Matuszewski W, et al. J Clin Med. 2021 Feb 11;10(4):705. doi: 10.3390/jcm10040705. J Clin Med. 2021. PMID: 33670143 Free PMC article. Review. - Role of Nitric Oxide and Hydrogen Sulfide in Ischemic Stroke and the Emergent Epigenetic Underpinnings.
Narne P, Pandey V, Phanithi PB. Narne P, et al. Mol Neurobiol. 2019 Mar;56(3):1749-1769. doi: 10.1007/s12035-018-1141-6. Epub 2018 Jun 20. Mol Neurobiol. 2019. PMID: 29926377 Review. - Mice generated by in vitro fertilization exhibit vascular dysfunction and shortened life span.
Rexhaj E, Paoloni-Giacobino A, Rimoldi SF, Fuster DG, Anderegg M, Somm E, Bouillet E, Allemann Y, Sartori C, Scherrer U. Rexhaj E, et al. J Clin Invest. 2013 Dec;123(12):5052-60. doi: 10.1172/JCI68943. Epub 2013 Nov 25. J Clin Invest. 2013. PMID: 24270419 Free PMC article. - Epigenetics of Cardiovascular Disease - A New "Beat" in Coronary Artery Disease.
Turgeon PJ, Sukumar AN, Marsden PA. Turgeon PJ, et al. Med Epigenet. 2014 Apr;2(1):37-52. doi: 10.1159/000360766. Med Epigenet. 2014. PMID: 25408699 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources